Monitoring a patient’s respiratory status usually takes place in a hospital setting and may be the primary purpose for a patient being observed or admitted to a medical setting. The physical signs of respiratory distress may present as a patient appearing short of breath, having an increased work of breathing, use of their accessory muscles, and changes in skin color, general pallor, or partial or complete loss of consciousness. Technological advancement, rising respiratory disorders and geriatric population worldwide are the major factors driving the growth of the global respiratory monitoring devices market.
The global respiratory monitoring devices market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on product types (impulse oscillometry/forced oscillation technique, plethysmography, spirometry), and forecasts growth trends (CAGR% – 2017 to 2021).
The global respiratory monitoring devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global respiratory monitoring devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global respiratory monitoring devices market and included in this report are CareFusion Corporation, COSMED, GE Healthcare, Masimo Corporation, Medtronic plc, MGC Diagnostic Corporation, ndd Medical Technologies, Inc., NIHON KOHDEN CORPORATION, Philips Healthcare, and Smith’s Medical.